Evidence map›Paper›PMID 28388943›Full record

ArticleBMC medical research methodology2017

Time-dependent ROC curve analysis in medical research: current methods and applications.

Adina Najwa Kamarudin, Trevor Cox, Ruwanthi Kolamunnage-Dona

Registry-linked trialAbstract read
In one paragraph

Article in BMC medical research methodology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06133374 (Concordance of Molecular Classification Based on Fine Needle Biopsy), which is not on this map. Cited by 482 papers.

0numbers the graph read from it
0cells of the map it votes in
482citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06133374 recruitingnot on this mapstarted 2024, after this paper: background citation

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

TypeobservationalSponsorUniversity of CalgaryRan2024 to 2028Enrolled130ConditionsPapillary Thyroid Cancer
3 · Its place in the literature

Who cites it

482 citing papers in PubMed.

  1. Trial
  2. Discovery of functional compounds from dimorphic edibleSynthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

422 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Adina Najwa KamarudinDepartment of Biostatistics, University of Liverpool, Liverpool, L69 3GL, UK. a.kamarudin@liverpool.ac.uk.
Trevor CoxDepartment of Biostatistics, University of Liverpool, Liverpool, L69 3GL, UK.
Ruwanthi Kolamunnage-DonaDepartment of Biostatistics, University of Liverpool, Liverpool, L69 3GL, UK.

Funding

Medical Research Council MR/M013227/1
6 · The paper itself

Abstract

backgroundROC (receiver operating characteristic) curve analysis is well established for assessing how well a marker is capable of discriminating between individuals who experience disease onset and individuals who do not. The classical (standard) approach of ROC curve analysis considers event (disease) status and marker value for an individual as fixed over time, however in practice, both the disease status and marker value change over time. Individuals who are disease-free earlier may develop the disease later due to longer study follow-up, and also their marker value may change from baseline during follow-up. Thus, an ROC curve as a function of time is more appropriate. However, many researchers still use the standard ROC curve approach to determine the marker capability ignoring the time dependency of the disease status or the marker.

methodsWe comprehensively review currently proposed methodologies of time-dependent ROC curves which use single or longitudinal marker measurements, aiming to provide clarity in each methodology, identify software tools to carry out such analysis in practice and illustrate several applications of the methodology. We have also extended some methods to incorporate a longitudinal marker and illustrated the methodologies using a sequential dataset from the Mayo Clinic trial in primary biliary cirrhosis (PBC) of the liver.

resultsFrom our methodological review, we have identified 18 estimation methods of time-dependent ROC curve analyses for censored event times and three other methods can only deal with non-censored event times. Despite the considerable numbers of estimation methods, applications of the methodology in clinical studies are still lacking.

conclusionsThe value of time-dependent ROC curve methods has been re-established. We have illustrated the methods in practice using currently available software and made some recommendations for future research.

Indexed as

Area Under CurveModels, StatisticalROC CurveBiomarkersComputer SimulationHumansLiverLiver Cirrhosis, BiliaryBiomarkersBiomarker evaluationEvent-timeLongitudinal dataROC curveSoftwareTime-dependent AUC

Identifiers

PMID28388943
PMCPMC5384160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.